TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.74 -0.06 (-8.81%) -0.02 (-2.29%) -0.02 (-2.29%) 0.01 (1.11%) -0.06 (-8.81%) 0.42 (94.36%) -0.14 (-16.57%) -0.17 (-19.97%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.3487
Diluted P/E:
-0.3487
RSI(14) 1m:
24.51
VWAP:
0.69
RVol:
0.0616

Events

Period Kind Movement Occurred At
1m Price decrease 1m 0.68 -0.01 (-1.37%) Oct 15 18:02
1m Price increase 1m 0.68 +0.01 (+1.18%) Oct 15 18:01
60m Price increase 60m 0.68 +0.04 (+5.97%) Oct 15 18:01
1m Price increase 1m 0.66 +0.02 (+3.6%) Oct 15 18:00
10m Price increase 10m 0.66 +0.02 (+3.6%) Oct 15 18:00

Related News